FDA mulls compounding for peptides previously flagged over safety risks BioSpace Peptide Therapy in Boise Specialized Treatment for First Responders Blueline Wellness The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Orthopedic Use of BPC 157 Sports Med Review